Radiobiological estimation of radiation‑induced heart complication of postmastectomy radiation therapy patients using the relative seriality model
Article Sidebar
Views | PDF/EPUB Downloads:
98
/ 4
/ 8
Main Article Content
Abstract
Background and Aim: In Nigeria today, most radiotherapy (RT) centers do manual planning using anatomical landmarks rather than precise planning using imaging modalities such as Computerized Tomography and Magnetic Resonance Imaging. This puts the collateral organs at a greater risk of damage. The objective of this study is to carry out a comparison of the risk of cardiac complication in the right and left breasts of postmastectomy radiation therapy patients using radiobiological evaluation tools.
Methods: Ninety-six patients treated in the University of Benin Teaching Hospital, RT Center, Nigeria, between January 2012 and March 2014 were recruited for this study. The relative seriality model was used to compute the risk of cardiac mortality to the breast of these patients.
Results: The results showed that the equivalent uniform dose (EUD) to the heart for patients with left breast cancer is significantly (P < 0.05) higher than the EUD to the heart of patients with right breast and also the risk of cardiac mortality is significantly (P < 0.05) higher in the left breast than the right breast; due to proximity to the heart to the left side.
Conclusion: This implies that the long-term risk of having cardiac disease should be of particular concern for women treated for left-sided breast cancer. As a result of this, care should be taken in planning patients using computerized treatment planning system that embraces imaging simulation rather than the conventional anatomical landmark; this will go a long way to prevent cardiac-induced mortality especially in cancer of the left breast.
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
How to Cite
References
1. Favourable and unfavourable effects on long‑term survival of radiotherapy for early breast cancer: An overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative Group. Lancet 2000;355:1757‑70.
2. Clarke M, Collins R, Darby S, Davies C, Elphinstone P, Evans V, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15‑year survival: An overview of the randomised trials. Lancet 2005;366:2087‑106.
3. Rutqvist LE, Rose C, Cavallin‑Ståhl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 2003;42:532‑45.
4. Fisher B, Costantino J, Redmond C, FisherE, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993;328:1581‑6.
5. Fisher B, Dignam J, Wolmark N, Mamounas E, Costantino J, Poller W, et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from national surgical adjuvant breast and bowel project B‑17. J Clin Oncol 1998;16:441‑52.
6. Madan R, Benson R, Sharma DN, Julka PK, Rath GK. Radiation induced heart disease: Pathogenesis, management and review literature. J Egypt Natl Canc Inst 2015;27:187‑93.
7. Zinzani PL, Gherlinzoni F, Piovaccari G, Frezza G, Bendandi M, Ferretti RM, et al. Cardiac injury as late toxicity of mediastinal radiation therapy for Hodgkin’s disease patients. Haematologica 1996;81:132‑7.
8. Emami B, Lyman J, Brown A, Coia L, Goitein M, Munzenrider JE, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21:109‑22.
9. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22:887‑96.
10. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, et al. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950‑2003. BMJ 2010;340:b5349.
11. Cuzick J, Stewart H, Peto R, Baum M, Fisher B, Host H, et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast
cancer. Cancer Treat Rep 1987;71:15‑29.
12. Paszat LF, Mackillop WJ, Groome PA, Boyd C, Schulze K, Holowaty E, et al. Mortality from myocardial infarction after adjuvant radiotherapy
for breast cancer in the surveillance, epidemiology, and end‑results cancer registries. J Clin Oncol 1998;16:2625‑31.
13. Niemierko AA. Generalized concept of equivalent uniform dose (EUD). Med Phys 1999;26:1100.
14. Niemierko A. Reporting and analyzing dose distributions: A concept of equivalent uniform dose. Med Phys 1997;24:103‑10.
15. Källman P, Agren A, Brahme A. Tumour and normal tissue responses to fractionated non‑uniform dose delivery. Int J Radiat Biol 1992; 62:249‑62.
16. Gagliardi G, Bjöhle J, Lax I, Ottolenghi A, Eriksson F, Liedberg A, et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000;46:373‑81.
17. Taylor CW, Brønnum D, Darby SC, Gagliardi G, Hall P, Jensen MB, et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977‑2001. Radiother Oncol 2011;100:176‑83.
18. Haybittle JL, Brinkley D, Houghton J, A’Hern RP, Baum M. Postoperative radiotherapy and late mortality: Evidence from the Cancer Research Campaign trial for early breast cancer. BMJ 1989;298:1611‑4.
19. Cuzick J, Stewart H, Rutqvist L, Houghton J, Edwards R, Redmond C, et al. Cause‑specific mortality in long‑term survivors of breast cancer
who participated in trials of radiotherapy. J Clin Oncol 1994;12:447‑53.
20. Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long‑term cardiac morbidity and mortality in a randomized trial of pre‑ and postoperative
radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 1998;48:185‑90.
21. Hooning MJ, Aleman BM, van Rosmalen AJ, Kuenen MA, Klijn JG, van Leeuwen FE, et al. Cause‑specific mortality in long‑term survivors
of breast cancer: A 25‑year follow‑up study. Int J Radiat Oncol Biol Phys 2006;64:1081‑91.
22. Darby SC, McGale P, Taylor CW, Peto R. Long‑term mortality from heart disease and lung cancer after radiotherapy for early breast cancer:
Prospective cohort study of about 300,000 women in US SEER cancer registries. Lancet Oncol 2005;6:557‑65.
23. Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A, et al. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: Nationwide cohort study of 90 000 Swedish women. BMJ 2003;326:256‑7.
24. Noel G, Mazeron JJ. Locoregional radiotherapy postmastectomy for breast cancer: Literature review. Cancer Radiother 2000;4:3‑26.
25. Taylor CW, McGale P, Darby SC. Cardiac risks of breast‑cancer radiotherapy: A contemporary view. Clin Oncol (R Coll Radiol) 2006;18:236‑46.
26. Paszat LF, Vallis KA, Benk VM, Groome PA, Mackillop WJ, Wielgosz A, et al. A population‑based case‑cohort study of the risk of myocardial infarction following radiation therapy for breast cancer. Radiother Oncol 2007;82:294‑300.
27. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS, et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005;97:419‑24.
28. BorgerJH, Hooning MJ, Boersma LJ, Snijders‑KeilholzA, Aleman BM, Lintzen E, et al. Cardiotoxic effects of tangential breast irradiation in
early breast cancer patients: The role of irradiated heart volume. Int J Radiat Oncol Biol Phys 2007;69:1131‑8.
29. Bouillon K, Haddy N, Delaloge S, Garbay JR, Garsi JP, Brindel P, et al. Long‑term cardiovascular mortality after radiotherapy for breast
cancer. J Am Coll Cardiol 2011;57:445‑52.